PEI

About

In the development of industrial-grade transfection reagents, an ideal non-viral vector should exhibit excellent cell adhesion and high transfection efficiency without the need for lysosomal inhibitors. Such reagents bind DNA through electrostatic interactions, forming compact, positively charged complexes that facilitate cell membrane interaction and promote efficient endocytosis. However, conventional cationic polymers often cause cell damage due to their positive surface charge, limiting their application in gene delivery. To overcome this, Yeasen Biotechnology leverages AI-driven molecular dynamics and docking technologies to develop a new generation of transfection reagents. These products maintain high transfection efficiency while offering significantly improved stability and biosafety—providing a more reliable and low-toxicity solution for high-throughput industrial-scale transfection. Product Selection Guide